Long-acting insulin therapies (two formulations included in study)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Long-acting insulin therapies (two formulations included in study), covering 2018-04-20 to 2018-04-20. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Compare the Effect of a Double Dose of Two Long-acting Insulin Therapies in Participants With Type 2 Diabetes [Phase 3]